SG Finserve Limited Files Q3FY26 Monitoring Agency Report with No Deviations
SG Finserve Limited filed its Q3FY26 monitoring agency report showing compliance with fund utilization objectives. The company received ₹112.50 crores from its ₹450.00 crore warrant issue and fully utilized the amount for working capital needs. CARE Ratings Limited reported no deviations from disclosed objects, though noted the current share price of ₹388.10 is below the issue price of ₹450.00.

*this image is generated using AI for illustrative purposes only.
SG Finserve Limited has submitted its quarterly monitoring agency report for the period ended December 31, 2025, to the stock exchanges on January 23, 2026. The report, mandated under Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, was prepared by CARE Ratings Limited as the appointed monitoring agency.
Issue Details and Fund Utilization
The monitoring report pertains to the company's preferential issue of warrants convertible into equity shares, with a total issue size of ₹450.00 crores. The issue has an 18-month period from the date of allotment for conversion.
| Parameter | Details |
|---|---|
| Issue Size | ₹450.00 crores |
| Issue Type | Preferential issue of warrants |
| Issue Period | 18 months from allotment date |
| Amount Received | ₹112.50 crores (25% of total) |
| Monitoring Agency | CARE Ratings Limited |
Fund Allocation and Progress
The proceeds from the warrant issue are allocated across two primary objectives. The major portion of ₹440.00 crores is designated for meeting working capital needs, while ₹10.00 crores is earmarked for general corporate purposes.
| Object | Proposed Amount (₹ Crores) | Amount Received (₹ Crores) | Amount Utilized (₹ Crores) | Unutilized Amount (₹ Crores) |
|---|---|---|---|---|
| Working Capital Needs | 440.00 | 112.50 | 112.50 | 0.00 |
| General Corporate Purpose | 10.00 | 0.00 | 0.00 | 0.00 |
| Total | 450.00 | 112.50 | 112.50 | 0.00 |
Compliance and Monitoring Status
CARE Ratings Limited confirmed that all utilization aligns with disclosures in the offer document. The monitoring agency reported no deviations from the objects or purposes for which funds were raised during the quarter ended December 31, 2025.
Key compliance parameters assessed include:
- No material deviations from expenditures disclosed in the offer document
- No changes in means of finance for disclosed objects
- No major deviations observed from previous monitoring reports
- All utilization as per offer document disclosures
Market Price Consideration
The monitoring agency highlighted that the company's share price stood at ₹388.10 at the end of trading on January 19, 2026, which is below the issue price of ₹450.00 per share. This indicates that investors would pay a premium compared to the current market price upon warrant conversion.
Implementation Timeline
The company maintains its timeline for fund utilization, with working capital needs to be completed by April 30, 2027. No delays have been reported in the implementation of stated objects, and the monitoring agency confirmed that the company is progressing as planned.
The report was reviewed and approved by the company's Audit Committee and Board of Directors in their meeting held on January 23, 2026, before submission to the stock exchanges.
Historical Stock Returns for SG Finserv
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -7.28% | -11.95% | -14.68% | -12.50% | -12.50% | -12.50% |


































